Influence of chemotherapy on postural control and quality of life in women with gynaecological cancer: a protocol of a prospective observational study

Introduction Chemotherapy-induced peripheral neuropathy is a frequent side effect of some chemotherapies that can cause postural control disorders and has a serious impact on quality of life (QoL). An enhanced understanding of postural control dysfunction could help build a systematic and accurate assessment as well as specific exercises to limit the impact on QoL. This study aims to assess the influence of chemotherapy on postural control and the QoL for women with gynaecological cancer. Methods and analysis This prospective observational study will include 37 participants with cancer treated using neurotoxic chemotherapy. Their postural control in various conditions (rigid and foam surfaces, eyes open and closed, with and without tendon vibration, and dual tasks), limits of stability, QoL and modified Total Neuropathy Score will be assessed. A linear mixed model will compare postural control pre-chemotherapy and post-chemotherapy. Ethics and dissemination This study was approved by an ethical review board in Geneva (CCER-2020-01639). The study findings will be disseminated through conference presentations and publications in peer-reviewed journals. Trial registration number NCT04692168.

[1]  N. Vayatis,et al.  A review of center of pressure (COP) variables to quantify standing balance in elderly people: Algorithms and open‐access code , 2021, Physiological reports.

[2]  Allison B. Wang,et al.  A review of movement disorders in chemotherapy-induced neurotoxicity , 2021, Journal of NeuroEngineering and Rehabilitation.

[3]  Joshua L. Haworth,et al.  Validation of a Portable Force Plate for Evaluating Postural Sway , 2020, Perceptual and motor skills.

[4]  C. Loprinzi,et al.  The Physical Consequences of Chemotherapy-Induced Peripheral Neuropathy , 2020, Current Oncology Reports.

[5]  J. Wiskemann,et al.  Out of balance - Postural control in cancer patients before and after neurotoxic chemotherapy. , 2020, Gait & posture.

[6]  C. Ketcham,et al.  Examination of clinical and laboratory measures of static and dynamic balance in breast cancer survivors , 2019, Physiotherapy theory and practice.

[7]  G. Akyuz,et al.  The Effect of Therapeutic Exercises on Balance, Quality of Life, and Pain in Patients Who Were Receiving Neurotoxic Chemotherapy , 2019, American journal of physical medicine & rehabilitation.

[8]  M. Friedlander,et al.  Balance Deficits and Functional Disability in Cancer Survivors Exposed to Neurotoxic Cancer Treatments. , 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

[9]  Paul A. Harris,et al.  The REDCap consortium: Building an international community of software platform partners , 2019, J. Biomed. Informatics.

[10]  F. Horak,et al.  Postural sway, falls, and self-reported neuropathy in aging female cancer survivors. , 2019, Gait & posture.

[11]  C. Loprinzi,et al.  Impaired Postural Control and Altered Sensory Organization During Quiet Stance Following Neurotoxic Chemotherapy: A Preliminary Study , 2019, Integrative cancer therapies.

[12]  Q. Mao-Ying,et al.  Prevention and Treatment for Chemotherapy-Induced Peripheral 
Neuropathy: Therapies Based on CIPN Mechanisms , 2019, Current neuropharmacology.

[13]  V. Hatzitaki,et al.  Putting proprioception for balance to the test: Contrasting and combining sway referencing and tendon vibration. , 2019, Gait & posture.

[14]  A. Nouvenne,et al.  Muscle weakness, cognitive impairment and their interaction on altered balance in elderly outpatients: results from the TRIP observational study , 2018, Clinical interventions in aging.

[15]  T. Tsuji,et al.  Differences in Balance Function Between Cancer Survivors and Healthy Subjects: A Pilot Study , 2018, Integrative cancer therapies.

[16]  C. Pui,et al.  Peripheral Neuropathy, Sensory Processing, and Balance in Survivors of Acute Lymphoblastic Leukemia. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  J. Joo,et al.  Development and Validation of Ovarian Symptom Index-18 and Neurotoxicity-4 for Korean Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer , 2018, Cancer research and treatment : official journal of Korean Cancer Association.

[18]  J. Challis,et al.  Comparison of posture and balance in cancer survivors and age‐matched controls , 2017, Clinical biomechanics.

[19]  Andrew J. Strubhar,et al.  Changes in Gait and Texting Ability During Progressively Difficult Gait Tasks , 2017, International journal of exercise science.

[20]  B. Ramaswamy,et al.  Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients , 2017, Breast Cancer Research and Treatment.

[21]  A. Effenberg,et al.  Effects of dual tasks and dual-task training on postural stability: a systematic review and meta-analysis , 2017, Clinical interventions in aging.

[22]  A. Chaudhari,et al.  Effect of chemotherapy-induced peripheral neuropathy on postural control in cancer survivors. , 2017 .

[23]  Xueliang Pan,et al.  Natural history of postural instability in breast cancer patients treated with taxane-based chemotherapy: A pilot study. , 2016, Gait & posture.

[24]  A. Gollhofer,et al.  Balance impairments and neuromuscular changes in breast cancer patients with chemotherapy-induced peripheral neuropathy , 2016, Clinical Neurophysiology.

[25]  Michael Schwenk,et al.  Interactive Sensor-Based Balance Training in Older Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy: A Randomized Controlled Trial , 2015, Gerontology.

[26]  S. Mesure,et al.  Hemispheric specificity for proprioception: Postural control of standing following right or left hemisphere damage during ankle tendon vibration , 2015, Brain Research.

[27]  Gillian L. Currie,et al.  Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis , 2014, PAIN®.

[28]  Winfried Banzer,et al.  Functional capacity and fear of falling in cancer patients undergoing chemotherapy. , 2014, Gait & posture.

[29]  O. Lennon,et al.  Chemotherapy induced peripheral neuropathy: the modified total neuropathy score in clinical practice , 2014, Irish Journal of Medical Science.

[30]  D. Pérennou.  Physiologie et physiopathologie du contrôle postural , 2012 .

[31]  Kathryn M Sibley,et al.  Balance Assessment Practices and Use of Standardized Balance Measures Among Ontario Physical Therapists , 2011, Physical Therapy.

[32]  Bruce Walker,et al.  The test-retest reliability of centre of pressure measures in bipedal static task conditions--a systematic review of the literature. , 2010, Gait & posture.

[33]  Jeffrey A. Cohen,et al.  The Reliability and Validity of a Modified Total Neuropathy Score-Reduced and Neuropathic Pain Severity Items When Used to Measure Chemotherapy-Induced Peripheral Neuropathy in Patients Receiving Taxanes and Platinums , 2010, Cancer nursing.

[34]  M. Mancini,et al.  The age-related changes of trunk responses to Achilles tendon vibration , 2009, Neuroscience Letters.

[35]  E. Erdfelder,et al.  Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses , 2009, Behavior research methods.

[36]  N. Vuillerme,et al.  Test-retest reliability of centre of foot pressure measures to assess postural control during unperturbed stance. , 2009, Medical engineering & physics.

[37]  M. Patel,et al.  The effect of foam surface properties on postural stability assessment while standing. , 2008, Gait & posture.

[38]  K. Słomka,et al.  Evaluation of the Limits of Stability (LOS) Balance Test , 2008 .

[39]  N. Byl,et al.  Quantitative and clinical description of postural instability in women with breast cancer treated with taxane chemotherapy. , 2007, Archives of physical medicine and rehabilitation.

[40]  Mary Ann Holbein-Jenny,et al.  Validity of functional stability limits as a measure of balance in adults aged 23–73 years , 2007, Ergonomics.

[41]  D. Cella,et al.  Validation and reduction of FACT/GOG-Ntx subscale for platinum/paclitaxel-induced neurologic symptoms: a gynecologic oncology group study , 2006, International Journal of Gynecologic Cancer.

[42]  L. Padua,et al.  Multi‐center assessment of the Total Neuropathy Score for chemotherapy‐induced peripheral neurotoxicity , 2006, Journal of the peripheral nervous system : JPNS.

[43]  A. Lissoni,et al.  Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[44]  D. Fishman,et al.  Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy , 2003, International Journal of Gynecologic Cancer.

[45]  J. P. Paul,et al.  What is balance? , 2000, Clinical rehabilitation.

[46]  D. Cella,et al.  Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system , 1996, Quality of Life Research.

[47]  D. Yuce,et al.  Learning effect of dynamic postural stability evaluation system. , 2019, Journal of back and musculoskeletal rehabilitation.

[48]  L. Cugusi,et al.  Effects of exercise on cancer patients suffering chemotherapy-induced peripheral neuropathy undergoing treatment: A systematic review. , 2018, Critical reviews in oncology/hematology.

[49]  D. Iżycki,et al.  Chemotherapy-induced peripheral neuropathy - epidemiology and pathogenesis. , 2016, Ginekologia polska.

[50]  P. Gagey,et al.  Pratiques en Posturologie , 2016 .

[51]  N. Byl,et al.  The Modified Total Neuropathy Score: A Clinically Feasible and Valid Measure of Taxane-Induced Peripheral Neuropathy in Women With Breast Cancer , 2006 .

[52]  A Cappello,et al.  Human postural response to lower leg muscle vibration of different duration. , 2006, Physiological research.